170 related articles for article (PubMed ID: 26431279)
1. Naa10 in development and disease.
Myklebust LM; Støve SI; Arnesen T
Oncotarget; 2015 Oct; 6(33):34041-2. PubMed ID: 26431279
[No Abstract] [Full Text] [Related]
2. Expanding the Phenotype Associated with NAA10-Related N-Terminal Acetylation Deficiency.
Saunier C; Støve SI; Popp B; Gérard B; Blenski M; AhMew N; de Bie C; Goldenberg P; Isidor B; Keren B; Leheup B; Lampert L; Mignot C; Tezcan K; Mancini GM; Nava C; Wasserstein M; Bruel AL; Thevenon J; Masurel A; Duffourd Y; Kuentz P; Huet F; Rivière JB; van Slegtenhorst M; Faivre L; Piton A; Reis A; Arnesen T; Thauvin-Robinet C; Zweier C
Hum Mutat; 2016 Aug; 37(8):755-64. PubMed ID: 27094817
[TBL] [Abstract][Full Text] [Related]
3.
Kweon HY; Lee MN; Dorfel M; Seo S; Gottlieb L; PaPazyan T; McTiernan N; Ree R; Bolton D; Garcia A; Flory M; Crain J; Sebold A; Lyons S; Ismail A; Marchi E; Sonn SK; Jeong SJ; Jeon S; Ju S; Conway SJ; Kim T; Kim HS; Lee C; Roh TY; Arnesen T; Marmorstein R; Oh GT; Lyon GJ
Elife; 2021 Aug; 10():. PubMed ID: 34355692
[TBL] [Abstract][Full Text] [Related]
4. NAA10 p.(N101K) disrupts N-terminal acetyltransferase complex NatA and is associated with developmental delay and hemihypertrophy.
McTiernan N; Gill H; Prada CE; Pachajoa H; Lores J; ; Arnesen T
Eur J Hum Genet; 2021 Feb; 29(2):280-288. PubMed ID: 32973342
[TBL] [Abstract][Full Text] [Related]
5.
McTiernan N; Darbakk C; Ree R; Arnesen T
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255974
[TBL] [Abstract][Full Text] [Related]
6. A novel NAA10 p.(R83H) variant with impaired acetyltransferase activity identified in two boys with ID and microcephaly.
Ree R; Geithus AS; Tørring PM; Sørensen KP; Damkjær M; ; Lynch SA; Arnesen T
BMC Med Genet; 2019 Jun; 20(1):101. PubMed ID: 31174490
[TBL] [Abstract][Full Text] [Related]
7. A novel NAA10 variant with impaired acetyltransferase activity causes developmental delay, intellectual disability, and hypertrophic cardiomyopathy.
Støve SI; Blenski M; Stray-Pedersen A; Wierenga KJ; Jhangiani SN; Akdemir ZC; Crawford D; McTiernan N; Myklebust LM; Purcarin G; McNall-Knapp R; Wadley A; Belmont JW; Kim JJ; Lupski JR; Arnesen T
Eur J Hum Genet; 2018 Sep; 26(9):1294-1305. PubMed ID: 29748569
[TBL] [Abstract][Full Text] [Related]
8. N-α-acetyltransferase 10 (NAA10) in development: the role of NAA10.
Lee MN; Kweon HY; Oh GT
Exp Mol Med; 2018 Jul; 50(7):1-11. PubMed ID: 30054454
[TBL] [Abstract][Full Text] [Related]
9. Investigating the functionality of a ribosome-binding mutant of NAA15 using Saccharomyces cerevisiae.
Varland S; Arnesen T
BMC Res Notes; 2018 Jun; 11(1):404. PubMed ID: 29929531
[TBL] [Abstract][Full Text] [Related]
10. Confirmation of Ogden syndrome as an X-linked recessive fatal disorder due to a recurrent NAA10 variant and review of the literature.
Gogoll L; Steindl K; Joset P; Zweier M; Baumer A; Gerth-Kahlert C; Tutschek B; Rauch A
Am J Med Genet A; 2021 Aug; 185(8):2546-2560. PubMed ID: 34075687
[TBL] [Abstract][Full Text] [Related]
11. Truncating Variants in NAA15 Are Associated with Variable Levels of Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies.
Cheng H; Dharmadhikari AV; Varland S; Ma N; Domingo D; Kleyner R; Rope AF; Yoon M; Stray-Pedersen A; Posey JE; Crews SR; Eldomery MK; Akdemir ZC; Lewis AM; Sutton VR; Rosenfeld JA; Conboy E; Agre K; Xia F; Walkiewicz M; Longoni M; High FA; van Slegtenhorst MA; Mancini GMS; Finnila CR; van Haeringen A; den Hollander N; Ruivenkamp C; Naidu S; Mahida S; Palmer EE; Murray L; Lim D; Jayakar P; Parker MJ; Giusto S; Stracuzzi E; Romano C; Beighley JS; Bernier RA; Küry S; Nizon M; Corbett MA; Shaw M; Gardner A; Barnett C; Armstrong R; Kassahn KS; Van Dijck A; Vandeweyer G; Kleefstra T; Schieving J; Jongmans MJ; de Vries BBA; Pfundt R; Kerr B; Rojas SK; Boycott KM; Person R; Willaert R; Eichler EE; Kooy RF; Yang Y; Wu JC; Lupski JR; Arnesen T; Cooper GM; Chung WK; Gecz J; Stessman HAF; Meng L; Lyon GJ
Am J Hum Genet; 2018 May; 102(5):985-994. PubMed ID: 29656860
[TBL] [Abstract][Full Text] [Related]
12. NAA10 dysfunction with normal NatA-complex activity in a girl with non-syndromic ID and a de novo NAA10 p.(V111G) variant - a case report.
McTiernan N; Støve SI; Aukrust I; Mårli MT; Myklebust LM; Houge G; Arnesen T
BMC Med Genet; 2018 Mar; 19(1):47. PubMed ID: 29558889
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic and biochemical analysis of an international cohort of individuals with variants in NAA10 and NAA15.
Cheng H; Gottlieb L; Marchi E; Kleyner R; Bhardwaj P; Rope AF; Rosenheck S; Moutton S; Philippe C; Eyaid W; Alkuraya FS; Toribio J; Mena R; Prada CE; Stessman H; Bernier R; Wermuth M; Kauffmann B; Blaumeiser B; Kooy RF; Baralle D; Mancini GMS; Conway SJ; Xia F; Chen Z; Meng L; Mihajlovic L; Marmorstein R; Lyon GJ
Hum Mol Genet; 2019 Sep; 28(17):2900-2919. PubMed ID: 31127942
[TBL] [Abstract][Full Text] [Related]
14. Clinical Manifestations in a Girl with NAA10-Related Syndrome and Genotype-Phenotype Correlation in Females.
Maini I; Caraffi SG; Peluso F; Valeri L; Nicoli D; Laurie S; Baldo C; Zuffardi O; Garavelli L
Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34200686
[TBL] [Abstract][Full Text] [Related]
15. Severe syndromic ID and skewed X-inactivation in a girl with NAA10 dysfunction and a novel heterozygous de novo NAA10 p.(His16Pro) variant - a case report.
Bader I; McTiernan N; Darbakk C; Boltshauser E; Ree R; Ebner S; Mayr JA; Arnesen T
BMC Med Genet; 2020 Jul; 21(1):153. PubMed ID: 32698785
[TBL] [Abstract][Full Text] [Related]
16. NAA10 controls osteoblast differentiation and bone formation as a feedback regulator of Runx2.
Yoon H; Kim HL; Chun YS; Shin DH; Lee KH; Shin CS; Lee DY; Kim HH; Lee ZH; Ryoo HM; Lee MN; Oh GT; Park JW
Nat Commun; 2014 Nov; 5():5176. PubMed ID: 25376646
[TBL] [Abstract][Full Text] [Related]
17. The N-end rule pathway enzyme Naa10 supports epiblast specification in mouse embryonic stem cells by modulating FGF/MAPK.
Takekoshi D; Tokuzawa Y; Sakanaka M; Kato H
In Vitro Cell Dev Biol Anim; 2019 May; 55(5):355-367. PubMed ID: 30993557
[TBL] [Abstract][Full Text] [Related]
18. Variants in NAA15 cause pediatric hypertrophic cardiomyopathy.
Ritter A; Berger JH; Deardorff M; Izumi K; Lin KY; Medne L; Ahrens-Nicklas RC
Am J Med Genet A; 2021 Jan; 185(1):228-233. PubMed ID: 33103328
[TBL] [Abstract][Full Text] [Related]
19. NAA10 mutation causing a novel intellectual disability syndrome with Long QT due to N-terminal acetyltransferase impairment.
Casey JP; Støve SI; McGorrian C; Galvin J; Blenski M; Dunne A; Ennis S; Brett F; King MD; Arnesen T; Lynch SA
Sci Rep; 2015 Nov; 5():16022. PubMed ID: 26522270
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Lysine Acetyltransferase Activity of Recombinant Human ARD1/NAA10.
Vo TTL; Park JH; Lee EJ; Nguyen YTK; Han BW; Nguyen HTT; Mun KC; Ha E; Kwon TK; Kim KW; Jeong CH; Seo JH
Molecules; 2020 Jan; 25(3):. PubMed ID: 32013195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
